CBUS - Cibus Inc - Ordinary Shares - Class A
IEX Last Trade
6.78
-0.320 -4.720%
Share volume: 88,046
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$7.10
-0.32
-4.51%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-05 | 2022-08-04 | 2022-11-03 | 2023-03-03 | 2023-05-01 | 2023-08-10 | 2023-11-09 | |
| Assets | ||||||||
| Total Assets | 38.345 M | 32.017 M | 26.702 M | 22.421 M | 20.285 M | 814.268 M | 796.235 M | |
| Current Assets | 18.973 M | 12.863 M | 7.944 M | 4.132 M | 2.583 M | 54.846 M | 34.472 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 1.189 M | 1.002 M | 739.000 K | 606.000 K | 529.000 K | 3.093 M | 2.029 M | |
| Short Term Investments | 1.189 M | 1.002 M | 739.000 K | 606.000 K | 529.000 K | 3.093 M | 2.029 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 858.000 K | 560.000 K | |
| Current Cash | 17.285 M | 11.316 M | 7.031 M | 3.427 M | 2.054 M | 50.895 M | 31.883 M | |
| Total Non-current Assets | 19.372 M | 19.154 M | 18.758 M | 18.289 M | 17.702 M | 759.422 M | 761.763 M | |
| Property Plant Equipment | 5.125 M | 5.077 M | 4.859 M | 4.516 M | 4.104 M | 14.989 M | 17.197 M | |
| Other Assets | 175.000 K | 169.000 K | 163.000 K | 158.000 K | 105.000 K | 1.238 M | 1.444 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 135.379 M | 134.921 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 585.266 M | 585.266 M | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 38.345 M | 32.017 M | 26.702 M | 22.421 M | 20.285 M | 814.268 M | 796.235 M | |
| Total liabilities | 23.424 M | 18.258 M | 17.858 M | 15.188 M | 17.618 M | 329.955 M | 332.845 M | |
| Total current liabilities | 9.520 M | 4.501 M | 4.228 M | 1.662 M | 4.215 M | 22.445 M | 25.079 M | |
| Accounts Payable | 1.231 M | 620.000 K | 573.000 K | 515.000 K | 390.000 K | 3.960 M | 6.281 M | |
| Other liabilities | 73.000 K | 68.000 K | 80.000 K | 79.000 K | 61.000 K | 151.055 M | 159.087 M | |
| Current long term debt | 290.000 K | 246.000 K | 120.000 K | 97.000 K | 1.000 M | 1.726 M | 1.400 M | |
| Long term debt | 89.000 K | 37.000 K | 0.000 | 0.000 | 0.000 | 719.000 K | 731.000 K | |
| Other liabilities | 73.000 K | 68.000 K | 80.000 K | 79.000 K | 61.000 K | 151.055 M | 159.087 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 136.866 M | 129.104 M | |
| Total Shareholder equity | 14.921 M | 13.759 M | 8.844 M | 7.233 M | 2.667 M | 484.313 M | 463.390 M | |
| Common stock | 4.202 M | 4.666 M | 4.678 M | 4.852 M | 4.941 M | 6.136 M | 16.641 M | |
| Retained earnings | -200.879 M | -203.364 M | -209.314 M | -212.151 M | -217.545 M | -236.235 M | -262.664 M |